Juvenile Idiopathic Arthritis Archives

Biologic DMARD Response Reduces After 3 Months in Juvenile Idiopathic Arthritis

By

September 12, 2022

Researchers analyzed previous study data to evaluate early response trajectory to biologic disease-modifying antirheumatic drugs and identify early response predictors.

Rheumatoid Arthritis

What is the Quality of Life in Adults With Juvenile Idiopathic Arthritis vs. Adult-Onset Arthritis?

By

Steve Fiorillo

June 3, 2022

The effects of juvenile idiopathic arthritis (JIA) develop in childhood, but they can also extend into adulthood. This can put patients at risk of pain and joint damage. How does the quality of life of adults with JIA compare to that of adults with adult-onset forms of arthritis?

hands of a child with juvenile idiopathic arthritis

Pediatric Rheumatology

Prediction Model Distinguishes Juvenile Idiopathic Arthritis From Chronic Musculoskeletal Pain Syndrome

By

Sheila Jacobs

May 11, 2022

Researchers developed and validated a diagnostic prediction model to distinguish between juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome.

Pediatric Rheumatology

Severe COVID-19 Outcomes Rare Among Children and Young People With Rheumatic Diseases

By

Emily Pond

April 18, 2022

Researchers sought to determine the outcomes among pediatric patients with rheumatic disease and COVID-19.

Pediatric Rheumatology

What Is the Effect of Changing Medication Patterns on Remission Rates in JIA?

By

Rheumatology Advisor Contributing Writer

April 5, 2022

Significantly more patients with JIA stopped taking their medications over a period of 18 vs 8 years after disease onset.

Pediatric Rheumatology

American College of Rheumatology Releases Updated Guidelines for the Treatment of Juvenile Idiopathic Arthritis

By

Dhivya Haridass, PhD

March 25, 2022

The American College of Rheumatology (ACR) developed updated guidelines for the pharmacologic management of juvenile idiopathic arthritis, with a focus on treatment of oligoarthritis, temporomandibular joint arthritis, and systemic JIA.

Pediatric Rheumatology

Pediatric Rheumatologists Discuss the Current State and Future of Precision Medicine in Juvenile Idiopathic Arthritis

By

Tori Rodriguez, MA, LPC, AHC

February 4, 2022

Randy Cron, MD, PhD, Mara Becker, MD, MSCE, and Robert Fuhlbrigge, MD, PhD, provide a deeper insight into precision medicine-based approaches in juvenile idiopathic arthritis.

Pediatric Rheumatology

Stat Consult: Polyarticular Juvenile Idiopathic Arthritis

By

Kendra Church, MS, PA-C

January 5, 2022

This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of polyarticular juvenile idiopathic arthritis.

Pediatric Rheumatology

Medications and Medical Appointments Contribute to Highest Health Care Costs in Juvenile Idiopathic Arthritis

By

Rebecca Chu, PharmD, RPh

December 20, 2021

The aim of the systematic review was to collect information currently available on health care costs associated with JIA after the introduction of biologic therapies.

Rheum Advisor on Air

Rheum With a View: Management of JIA-Associated Uveitis in Adults

December 17, 2021

In this episode, Mara Becker, MD, highlights the importance of collaboration between ophthalmology and rheumatology for the management of adults with juvenile idiopathic arthritis-associated uveitis.